For instance, hypermethylation of ABCB1 and demethylation of the ABCG2 promoter may affect therapeutic efficacy and lead to chemoresistance in ovarian carcinoma, effects attributed to upregulation of P-gp [159, 160]. The gene discussed is ABCB1; the disease is ovarian carcinoma.